정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1017 | Recruiting | MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) | ARDS | Biological: MultiStem Biological: Placebo |
Phase 3 | Athersys, Inc | INDUSTRY | 400 | All | 18 Years ~ 89 Years | Athersys Investigational Site 107, Chicago, Illinois, United States Athersys Investigational Site 103, Akron, Ohio, United States Athersys Investigational Site 101, Cleveland, Ohio, United States Athersys Investigational Site 102, Cleveland, Ohio, United States |
| 1016 | Recruiting | Mushroom-based Product for COVID-19 | COVID-19 | Drug: FoTv | Phase 2 | Gordon Saxe, University of California, Los Angeles, University of California, Irvine | OTHER | 66 | All | 18 Years | University of California, Los Angeles, Los Angeles, California, United States University of California, San Diego, San Diego, California, United States |
| 1015 | Recruiting | NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Drug: Drug: NA-831 Combination Product: NA-831 and Atazanavir Combination Product: NA-831and Dexamethasone Combination Product: Atazanavir and Dexamethasone |
Phase 3 | NeuroActiva, Inc. | INDUSTRY | 525 | All | 18 Years ~ 80 Years | Coronavirus Research Institute- Testing Site, Los Angeles, California, United States Coronavirus Research Institute, Orange, California, United States Coronavirus Research Institute-Testing Site, Palo Alto, California, United States Coronavirus Research Institute-Testing Site, Sacramento, California, United States Coronavirus Research Institute-Testing Site, San Diego, California, United States Coronavirus Research Testing Site, San Francisco, California, United States Coronavirus Research Institute-Testing Site, Sunnyvale, California, United States Coronavirus Research Institute-Testing Site, Washington, District of Columbia, United States Coronavirus Research Institute-Testing Site, Washington, District of Columbia, United States Coronavirus Research Institute-Testing Site, Fort Lauderdale, Florida, United States Coronavirus Research Institute-Testing Site, Tampa, Florida, United States Coronavirus Research Institute- Testing Site, Chicago, Illinois, United States Coronavirus Research Institute-Testing Site, Naperville, Illinois, United States Coronavirus Research Institute-Testing Site, Baltimore, Maryland, United States Coronavirus Research Institute-Testing Site, Bethesda, Maryland, United States Coronavirus Research Institute-Testing Site, Boston, Massachusetts, United States Coronavirus Research Institute-Testing Site, Worcester, Massachusetts, United States Coronavirus Research Institute-Testing Site, Ann Arbor, Michigan, United States Coronavirus Research Institute-Testing Site, Detroit, Michigan, United States Coronavirus Research Institute-Testing Site, Newark, New Jersey, United States Coronavirus Research Institute-Testing Site-, Bronx, New York, United States Coronavirus Research Institute-Testing Site, New York, New York, United States Coronavirus Research Institute- Testing Site, Rochester, New York, United States Coronavirus Research Institute-Testing Site, Durham, North Carolina, United States Coronavirus Research Institute-Testing Site, Philadelphia, Pennsylvania, United States Coronavirus Research Institute- Testing Site, Fort Sam Houston, Texas, United States Coronavirus Research Institute-Testing Site, Galveston, Texas, United States Coronavirus Research Institute-Testing Site, Houston, Texas, United States Coronavirus Research Institute-Testing Site, Kirkland, Washington, United States Coronavirus Research Institute-Testing Site, Seattle, Washington, United States Coronavirus Research Institute-Testing Site, Tacoma, Washington, United States |
| 1014 | Not yet recruiting | NAC for Attenuation of COVID-19 Symptomatology | Oxidative Stress | Drug: N-acetylcysteine Other: Placebo |
Phase 2 | Cambridge Health Alliance, The Thoracic Foundation, Alturix | OTHER | 200 | All | 18 Years | Cambridge Health Alliance, Everett, Massachusetts, United States |
| 1013 | Recruiting | Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults | COVID - 19 | Drug: Poly-ICLC (Hiltonol®) or Placebo Drug: Poly-ICLC (Hiltonol®) or Placebo |
Phase 1 | Oncovir, Inc., University of Calgary | INDUSTRY | 43 | All | 18 Years ~ 69 Years | Health Research Innovation Centre, Calgary, Alberta, Canada |
| 1012 | Terminated | NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19) | Coronavirus Infection | Biological: NasoVAX Other: Placebo |
Phase 2 | Altimmune, Inc. | INDUSTRY | 48 | All | 18 Years | Miami Dade Medical Research Institute, Miami, Florida, United States Infinite Clinical Trials, Morrow, Georgia, United States Cedar Crosse Research Center, Chicago, Illinois, United States Carolina Institute for Clinical Research, Fayetteville, North Carolina, United States Next Level Urgent Care, Houston, Texas, United States Centex Studies, Houston, Texas, United States Centex Studies, McAllen, Texas, United States |
| 1011 | Recruiting | National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE) | SARS-CoV Infection | Biological: COMIRNATY - BioNTech Manufacturing GmbH Biological: COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH Biological: COVID-19 Vaccine AstraZeneca suspension for injection |
Phase 4 | Jens D Lundgren, MD, Ministry of the Interior and Health, Denmark | OTHER | 10000 | All | 18 Years | Aarhus Universitetshospital, Skejby, Aarhus, Aarhus N, Denmark Aalborg Universityhospital Syd, Aalborg, Denmark Hvidovre Hospital, Hvidovre, Denmark Odense Universityhospital, Odense, Denmark Sjællandsuniversitetshospital, Roskilde, Denmark |